Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Operating Income Loss of $179.64 million for the year ending 2025.
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +5.7% in Operating Income Loss from 2024 to 2025.
- This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Operating Income Loss has grown by 1,219.8%.
- Historical annual values: Fiscal year 2025: $179.64 million | Fiscal year 2024: $169.90 million | Fiscal year 2023: $166.96 million | Fiscal year 2022: $33.32 million | Fiscal year 2021: $17.63 million | Fiscal year 2020: $56.23 million | Fiscal year 2019: -$23.75 million | Fiscal year 2018: -$20.69 million | Fiscal year 2017: -$75.45 million | Fiscal year 2016: -$94.08 million | Fiscal year 2015: -$26.91 million | Fiscal year 2014: -$17.67 million | Fiscal year 2013: -$16.04 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: